From Complexity to Control: A Practical CHOExpress® Platform for Bispecific Antibody Development
9:30 am - Thursday 17th September 2026
- Getting the right bispecific from the start: How we address key development risks such as chain pairing, heterodimer formation, expression balance and unwanted product species early in cell line development
- Turning bispecific complexity into a robust platform: How ExcellGene has translated experience across different bispecific formats into practical technologies and development strategies designed to achieve high productivity together with the intended product profile
- Accelerating the path to manufacturing: How the CHOExpress® platform combines cell line development, process development and product-quality assessment to de-risk bispecific programs, shorten development timelines and generate scalable, manufacturing-ready cell lines
